EMR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Emerson Electric Co (EMR) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators show a bearish trend, and there are no significant positive catalysts in the short term. While the company's financial performance is solid and analysts have raised price targets, the recent price decline and lack of strong trading signals suggest waiting for a better entry point.
The stock is in a bearish trend with MACD negatively expanding (-0.585), RSI at 22.675 (neutral zone), and moving averages showing bearish alignment (SMA_200 > SMA_20 > SMA_5). The price is below key support levels, with the next support at 124.884.
The company has shown solid Q1 2026 financial performance, with revenue, net income, and EPS all increasing YoY. Analysts have raised price targets, citing strong order momentum and growth potential.
The stock has declined significantly in the regular market (-3.48%) and post-market (-0.47%), with no recent news or significant hedge fund or insider trading activity. Technical indicators are bearish, and the market sentiment is neutral.
In Q1 2026, Emerson reported a 4.10% YoY revenue increase to $4.346 billion, a 3.59% YoY net income increase to $606 million, and a 4.90% YoY EPS growth to $1.07. Gross margin also improved slightly to 48.46%.
Analysts have raised price targets, with the highest being $191 (BofA) and the lowest at $150 (BMO Capital). The consensus reflects optimism about order momentum and growth potential, but some analysts note limited upside in the near term.
